ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,218.19
0.77%
Dow Jones
40,287.53
-0.93%
Gold vs US Dollar
2,407.97
0.30%
Brent Oil
81.525
-0.92%
Bitcoin
67,451.34
-1.04%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
22/07/202412:00UK RegulatoryMiddleGround Capital enters into Investment Agreement with STEMMER IMAGING AG and announces intention to launch a Voluntary Public Takeover Offer
22/07/202412:00UK RegulatoryTilray Receives First New Cannabis Cultivation License in Germany Under New RegulationsTG:2HQTilray Brands Inc
22/07/202412:00UK RegulatoryMiddleGround Capital unterzeichnet Investmentvereinbarung mit STEMMER IMAGING AG und kündigt Absicht zur Abgabe eines freiwilligen öffentlichen Übernahmeangebots an
22/07/202412:00UK RegulatoryTilray Receives First New Cannabis Cultivation License in Germany Under New RegulationsLSE:0Z6YTilray Inc
22/07/202412:00UK RegulatoryTilray Receives First New Cannabis Cultivation License in Germany Under New RegulationsXE:2HQTilray Brands Inc
22/07/202412:00Alliance NewsAlliance NewsIrish wholesale inflation speeds up to 2.8% annually in June
22/07/202412:00PR Newswire (US)Gan & Lee Pharmaceuticals' Bi-weekly (twice a month) GLP-1 Receptor Agonist GZR18 Injection Achieved 17.29% Weight Loss at 30 Weeks in a Phase IIb Clinical Trial
22/07/202412:00PR Newswire (US)The Cigna Group Foundation Launches Its Health Equity Impact FundNYSE:CICigna Group
22/07/202412:00PR Newswire (US)GLOBE LIFE INC. ANNOUNCES SECOND QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALLNYSE:GLGlobe Life Inc
22/07/202412:00PR Newswire (US)OMNICOM MEDIA GROUP AGENCIES OUTPERFORM FOR GROWTH ACROSS ALL FOUR REGIONSNYSE:OMCOmnicom Group Inc
22/07/202412:00PR Newswire (US)BIRKENSTOCK OPENS ITS VERY FIRST OWN RETAIL STORE IN FRANCE
22/07/202412:00PR Newswire (US)The Cigna Group Foundation Launches Its Health Equity Impact FundNYSE:CICigna Group
22/07/202412:00PR Newswire (US)Gan & Lee Pharmaceuticals' Bi-weekly (twice a month) GLP-1 Receptor Agonist GZR18 Injection Achieved 17.29% Weight Loss at 30 Weeks in a Phase IIb Clinical Trial
22/07/202412:00PR Newswire (US)Worldwide C-130J Super Hercules Fleet Soars Past 3 Million Flight HoursNYSE:LMTLockheed Martin Corp
22/07/202412:00PR Newswire (US)Cornerstone Capital Bank Adds Seven Senior Executives to Leadership Team
22/07/202412:00UK RegulatoryInvesco Global Equity Income Trust Plc - Net Asset Value(s)LSE:IGETInvesco Global Equity Income Trust Plc
22/07/202412:00PR Newswire (US)Group Therapy Can Respond to Mental Health Crisis with Increased Access to Services While Reducing Costs
22/07/202412:00PR Newswire (US)LSC Environmental Products Acquires Benzaco Scientific, Inc.
22/07/202412:00PR Newswire (US)OceanaGold Announces Share Buyback ProgramTSX:OGCOceanaGold Corporation
22/07/202412:00PR Newswire (US)FalconPoint Partners Appoints Vijay Maharaj as Chief Financial Officer
22/07/202412:00PR Newswire (US)CGI announces Agile Catalyst™ framework for U.S. federal agenciesTSX:GIB.ACGI Inc
22/07/202412:00PR Newswire (US)Aura Biosciences Invests in InstantGMP QMS for Clinical Research Quality Assurance
22/07/202412:00PR Newswire (US)Ionis announces positive detailed results from the HALOS Study of ION582 in people with Angelman syndromeNASDAQ:IONSIonis Pharmaceuticals Inc
22/07/202412:00PR Newswire (US)Siyata Mobile Announces $1.2 Million Follow-on Order from a Leading International EMS CustomerNASDAQ:SYTASiyata Mobile Inc
22/07/202412:00PR Newswire (US)CGI announces Agile Catalyst™ framework for U.S. federal agenciesNYSE:GIBCGI Inc
22/07/202412:00PR Newswire (US)New Sit 'n Sleep Study Reveals Consumers' Top Mattress Preferences in 2024
22/07/202412:00PR Newswire (US)Magellan Behavioral Health of Pennsylvania, Inc. Earns NCQA Health Equity Accreditation
22/07/202412:00PR Newswire (US)BIRKENSTOCK OPENS ITS VERY FIRST OWN RETAIL STORE IN FRANCE
22/07/202412:00PR Newswire (US)Safety Concerns Peak as Election Approaches Says Fast Guard Service
22/07/202412:00PR Newswire (US)Flimp Launches New Brand Design and Website Offering Employers Turnkey Campaign Solutions for Benefits Communications and Decision Support

Your Recent History

BIT
F27638
Vontobel Financial Produ...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved